Assistant at Second University of Naples (University Vanvitelli), internal medicine - Caserta, Italy, 1999-2004.
Research Interest: thrombotic disorders and basic haemostasis
Waiting for Executive Editors.
Wei Du, University of Arkansas for Medical Science, USA
With many career avenues available to scientists today, I view academic research as the most productive pathway to test clinically relevant hypotheses through unbiased basic research. My graduate research at Tohoku University, Japan focused on the genetic mutations in Wiskott-Aldrich Syndrome. These projects resulted in the first report describing somatic mosaicism due to a spontaneous second-site mutation in the initiation codon. After completing my Ph.D. in 2007, I began my research work in Cincinnati Children’s Hospital Medical Center. During the last several years, my research has centered on pathophysiology of hematologic diseases such as bone marrow (BM) failure and leukemia. In addition, I have been investigating the mechanism of hematopoietic stem cell (HSC) mobilization and bone marrow niche engraftment as well as the factors implicated in cell proliferation and apoptosis. I have identified functional interactions between certain factors implicated in cell polarity, adhesion and migration. I have published 20 peer-reviewed scientific papers in high-impacted scientific journals of Hematology. Among them, I have been served as first-author for 10 times and Correspondingly-author for 5 times. My post-doctoral fellowship has been supported by a competitive Fanconi Anemia Research Fund (FARF) and a NIH T32 grant in Hematologic and Oncologic diseases.
Stem cell biology and pathophysiology of bone marrow failure and leukemia; identifying and targeting DNA damage response and repair pathways required for cancer progression; hematopoietic stem cell-bone marrow niche interaction.
Shyam A. Patel, Stanford University Medical Center, USA
I attended Rutgers – New Jersey Medical School from 2006-2013 where I completed the physician-scientist training program (PSTP) program. The disciplines in which I trained were stem cell and cancer biology. My thesis focused on the mechanisms of breast cancer dormancy in the bone marrow. In brief, we found that bone marrow mesenchymal stem cells (MSCs) can favor immune subversion of breast cancer cells by inhibiting various anti-tumor responses (Patel SA et al., J. Immunol. 2010; 184:5885-5894). Mechanistically, we found that MSCs induce Tregs and thus dampen immune effector responses against cancer. We also found that a subset of breast cancer cells, characterized by the expression of the pluripotency marker Oct4, is responsible for initiating tumors (Patel SA et al., Sci. Rep. 2012; 2:906). Finally, we showed the MSCs preferentially protect the cancer stem cell population in the bone marrow (Patel SA et al., J. Cancer Stem Cell Res. 2014; 2: e1003). My other interests are in the biology of acute myeloid leukemia. My research interests include tumor microenvironment, tumor immunology, translational cancer medicine, breast cancer biology, acute myeloid leukemia, and genomics.
My other interests are in the biology of acute myeloid leukemia. My research interests include tumor microenvironment, tumor immunology, translational cancer medicine, breast cancer biology, acute myeloid leukemia, and genomics.
Giuseppe Maurizio Campo, University of Messina, Italy
Dr. Giuseppe Maurizio Campo was born in Novara di Sicilia, Italy, September the 16th, 1963. He followed doctoral Degree Courses in Biological Sciences at the University' of Messina from 1987 to
1998 he attended the Institute of Pharmacology, School of Medicine at the University' of Messina. In years 1990-1992 he worked as scientific adviser of the FIDIA Research Laboratories of Abano Terme and the Cifa-gesco Consortium of Rome for the study and development of new drugs. In the October 1992 he obtained the Specialization Degree in "Biochemistry and Clinical Chemistry" at the University' of. Messina. In the year 1993 he obtained a postdoctoral scholarship of the CNR for
a stage at the Department of Medical Laboratory Sciences and Technology, at the Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden. In 1994 he got the PhD in "Experimental Medicine", at the University' of Messina. Since December 1998 Dr. Campo is Aggregate Professor of Biochemistry at the Department of Clinical and Experimental Medicine, School of Medicine, University of Messina.
With particular interest is currently being investigated the role of glycosaminoglycans, Hyaluronic acid especially, in experimental arthritis, both in vivo and in vitro together with all the mediators related to the inflammatory process.
Claudio Cerchione, University of Naples “Federico II”, Italy
Dr Claudio Cerchione graduated in medicine with honours from the Medical School at the University Federico II of Naples, Italy (July 2008). During his Fellowship and PhD studies, Dr. Cerchione carried out research under my supervision in the Division of Hematology at University Federico II of Naples, Italy, from July 2009 until now : he
studied in detail Hematological malignancies, and his main research interests are relapsed and refractory multiple myeloma and myelodysplastic syndromes. He started his collaboration in Hematology Department, AOU Federico II, Naples, Italy, in 2006, and there he completed with honours his Fellowship in July 2014 and is now attending last year of his PhD program. He also has spent one year in Friedrich-wilhelms universität, Bonn, Germany collaborating in their
Hematology Department, and one month in Universitade de Coimbra, Portugal, collaborating in their clinical and research projects. He is author/co-author of many articles (also as first author) in peer-reviewed international journals and he is member of the editorial board of one scientific journal, and more than 100 abstracts, presented at national and international congresses, and member of several international societies,
including the European Hematology Association and Italian Society of Hematology. He is a frequently invited speaker at national hematologic meetings, where he received also several national awards. Actually, he is co-responsible of MGUS and Mutiple Myeloma in our clinical and research division and of clinical trials in Multiple Myeloma.
Clinical management and research on Multiple Myeloma, with particular interest in imaging diagnostic techniques, alternative chemotherapy regimens and transplantation procedures.
1. Clinical management on Chronic Myeloid Leukemia, with research
interest on mechanisms of second generation TKIs.
2. Clinical management of Myelodysplastic Syndromes, with particular
interest on role of demethylating agents.
3. Clinical management of Pediatric Acute Leukemias.
4. Clinical management of Infections in Hematologic patients, with
particular interest in diagnostic tools and imaging techniques, especially
for invasive fungal infections.
Carmine Selleri, Department Pathology, Oncology, Hematology, AOU, Italy
Abraham Klepfish, Wolfson Medical Center, Israel
C. Balachandran, Fujita Health University, Japan
Rada M. Grubovic, Institute for Transfusion Medicine, Macedonia
Dr. Rada M. Grubovic is Head of Department for Stem Cell Collection at the Institute for Transfusion Medicine in Skopje, Republic of Macedonia. She is consultant in transfusion medicine since 2006 and hematology since 2014, and serves as a Vice President of Macedonian Association for Transfusion Medicine since 2012. Dr. Grubovic is JACIE inspector and external auditor for accreditation of medical institutions. She is assistant professor at the Medical Faculty in Skopje since 2008. She obtained the MD degree in 1999 and the MSci degree in 2007 from the Medical Faculty in Skopje, University Sts Cyril and Methodius. Dr. Grubovic is a PhD candidate in the field of Hematopoietic Stem Cell Collection and Transplantation. Most of her research work was done at the Bone Marrow Transplant Unit, Hematologic Malignancies, David Geffen School of Medicine at the UCLA, Los Angeles, California, USA while she was awarded with Fulbright scholarship in 2010/2011 and that collaboration still remains. In 2008 she was awarded with the Princes of Wales Memorial Scholarship by the British Society for Transfusion Medicine and she pursued her research at the King’s College Hospital in London, UK. She was external advisor of the Macedonian Minister of Health in 2011/2012 helping to establish the National Bone Marrow Donor Program and subsequent by-laws. Dr. Grubovic's scientific focus includes stem cell biology, mobilization, stem cell collection, hematopoietic stem cell transplantation, effects of mobilization and apheresis stem cell donation on voluntary donors, acute myeloid leukemia, multiple myeloma, lymphoma.
Hunan L Julhakyan, Hematological Scientific Center of Ministry of Health, Russian Federation
Having graduated from Medical University in Yerevan (with straight “A” Diploma received), I began my training program in Hematology Research Center as a resident (2003) and then as a PhD research fellow (2005). Since 2009 - staff hematologist in Hematological Scientific Center. I presented my PhD thesis in March 2011.
Research interests: Hodgkin’s and non- Hodgkin’s lymphomas, splenic marginal zone lymphoma and other lymphoproliferative disorders with splenomegaly.
Eloísa Urréchaga Igartua, Hospital de Galdakao, Spain
Medicine Laboratory, Clinical Analysis technology, obotics in Hematology
Iron and Anemia, Erythropoiesis, Glycohemoglobin.
Ke-seng Zhao, Southern Medical University, China
Ke-seng Zhao, Professor of Southern Medical University in Guangzhou, China. He was the founding member of International Federation of Shock Societies (FISS), Council member of Asian Union for Microcirculation (AUM), and the President of China Shock Society. He published 180 papers and 2 books about shock and microcirculation, which included the mechanism and treatment of severe shock with a new anti-shock medicine –Polydatin. He is a consulting board member of SHOCK, CLINIC, and the National Famous Teacher in China.
Shock, microcirculation, mitochondria.
Melda Cömert Özkan, Inonu University, Turkey
Vasile Musteata, State University of Medicine and Pharmacy “N. Testemitanu”, Institute of Oncology, Moldova, Republic of
Dr. Vasile Musteata completed his PhD and MPH at the age of 30 years and 39 years respectively after the postgraduate studies at the State University of Medicine and Pharmacy “N. Testemitanu” from the Republic of Moldova. Dr. Vasile Musteata is a licensed hematooncologist and associate professor, with a background of 20 years in clinical and translational researches in hematooncology. In 2011 he graduated successfully from the School of Public Health Management. Dr. Vasile Musteata is a master of Public Health Management. He was decorated the AIOM-Young Investigator Award and the Award for Youth in the domain of Sciences, Technology and Literature, on behalf of the Government of the Republic of Moldova. He is an associate professor and studies chief at the university department of Oncology, Hematology and Radiotherapy, the GIPAP responsible physician, EACR ambassador, iCMLf representative for Moldova and the European LeukemiaNet institutional participant. In 2012 Dr. Vasile Musteata successfully completed the ERSAP Preceptorship Program in the field of hematologic malignancies at MD Anderson Cancer Center,Houston, Texas, USA. Dr. Vasile Musteata published more than 150 articles and abstracts in reputed journals/abstract books. He serves as an editorial board member of the Journal of BUON.
Emmanuel ANDRES, University of Strasbourg, France
In 1996, Dr Andrès received his MD degree in Internal Medicine, at the University of Strasbourg, France. He worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann (2011, Nobel Prize of Medicine) in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France. He also was in the head of an Internal Medicine Department (of 62 beads) in the University hospital of Strasbourg, France. He was awarded the French Society of Haematology, price for research in the field of anaemia related to cobalamin or folate deficiencies in 2004. Achievements include development of research in: all type of anaemia, neutropenia and thrombocytopenia, particularly drug-induced neutropenia and agranulocytosis or thrombocytopenia; haematopoietic growth factors; and cobalamin deficiencies. He also conducts several studies on inflammatory or immune disorders. His recent works also include research and development on human sounds analysis, electronic stethoscope, e-auscultation, and e-medicine. In that function he was recruited as advisor to several pharmaceutical and telemedicine companies or start-up.
Ehsan Shahverdi, High Institute for Research and Education in Transfusion Medicine, Iran (Islamic Republic of)
Shahverdi is a MD medical graduate (2016), who commenced his interest in Blood transfusion, cancer treatment and researchin 2014. He completed a MD postgraduate qualifications before taking up positions in transfusion in Iranian Blood Transfusion Organization(IBTO)and then in cancer treatment and research in MAHAK Pediatric Cancer Treatment and Research Centerand Pediatric Growth and Development Research Center of the Institute of Endocrinology and Metabolism. He became Medical researcher of the Immunohematology Reference Laboratory of the Iranian Blood Transfusion Organization in 2014 before moving to the High Institute for Research and Education in Transfusion Medicine in 2015 and Pediatric Growth and Development Research Center of the Institute of Endocrinology and Metabolism in 2017, where he is now a clinical researcher in the Department of Immunohematology and endocrinology and metabolism.
Dr E. Shahverdi has been a Council member of the Blood and Cancer Research Center of the MAHAK Pediatric Cancer Treatment and Research Center and Pediatric Growth and Development Research Center of the Institute of Endocrinology and Metabolism. He is Chairman of the department of Young Doctors and Researchers of the IPHOS and Pediatric Growth and Development Research Center of the Institute of Endocrinology and Metabolism. His experience cover s all areas of transfusion medicine research.
He was secretary of the Young Researchers Panel of different national and international hematology and oncology congress for 5 years and chaired theirs Scientific Committee. Additionally, he has served on many other transfusion related organizations.
He has written over 60 scientific papers and is in demand as a speaker to a number of international congress. He has a particular interest in the transfusion services of developing countries and has travelled to many of them to lecture and assist in practical workshops.
Over the years, he has been awarded life memberships of various organizations and has won several prestigious awards from medical societies.
He is now very active in various community support organizations. His main interest is now in medical history and writing.